Source: EURLEX
Language: en
Format: md

[**Avis juridique important**](../../../editorial/legal_notice.htm)

*|*

# 91996E1467

**WRITTEN QUESTION No. 1467/96 by Hiltrud BREYER to the Commission. Research in the field of heterotransplantation** 
  
*Official Journal C 356 , 25/11/1996 P. 0041*

  

WRITTEN QUESTION E-1467/96 by Hiltrud Breyer (V) to the Commission (12 June 1996)

Subject: Research in the field of heterotransplantation

1. In what context, in what countries, in what research institutes, under what budget heading and to what extent does the EU directly and/or indirectly assist research in the field of heterotransplantation?

2. How does the Commission view the health hazards of heterotransplantation as a result of the transfer of such pathogens as bacteria, viruses and prions from animals to human beings?

3. Is the Commission assisting risk studies in this sector, or is it aware of studies and research projects in the Community relating to the possible risks inherent in heterotransplantation?

4. Does the Commission not agree that not only are biological and medical risks associated with heterotransplantation but also fundamental ethical and moral principles, which need to be discussed before further research is undertaken?

Answer given by Mrs Cresson on behalf of the Commission (16 July 1996)

No research project relating to heterotransplantation is currently being conducted within the programme of research in the field of biomedicine and health. This does not, of course, rule out such research in the future, as heterotransplantation is part of the work programme of research into medical bioethics.

[Top](#document1)